MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Namkung, M. J.
Right arrow Articles by Juchau, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Namkung, M. J.
Right arrow Articles by Juchau, M. R.

On the substrate specificity of cytochrome P450IIIA1

MJ Namkung, HL Yang, JE Hulla and MR Juchau

Department of Pharmacology, School of Medicine, University of Washington, Seattle 98195.

The instability of the solubilized/purified form, the lack of catalytic activity of the stabilized, macrolide-complexed form, and the compromised catalytic activity of the decomplexed form of steroid- inducible cytochrome P450IIIA1 motivated further investigations of the substrate specificity of this isozyme. A major complementary goal was to identify reactions utilizable as sensitive, specific diagnostic probes for the detection and partial characterization of this isozyme in tissues for which isolation and purification are not practical (e.g., extrahepatic, embryonic tissues, etc.). The approach utilized a combination of a specific, purified inducer, specific inhibitors including triacetyloleandomycin and inhibitory antibodies, and diagnostic probe substrates including the phenoxazone ethers, testosterone, warfarin, 2-acetylaminofluorene, estradiol-17 beta and benzo[a]pyrene. The results obtained indicated that steroid-inducible, rat hepatic P450IIIA1 would catalyze minimal or no O-dealkylation of methoxy-, ethoxy- or pentoxyphenoxazone but catalyzed rapid O- debenzylation of benzyloxyphenoxazone. Hydroxylation of testosterone was specific for the beta face of the molecule at the 2-, 6-, 15- and 16-positions with no detectable conversion to androstenedione and minimal hydroxylation on the alpha face. Both the R- and S-enantiomers of warfarin were attacked at positions 9 and 10, and these reactions appeared to be specific to isozymes of the IIIA family. Aromatic hydroxylation of estradiol-17 beta was efficiently catalyzed, particularly at the 2-position. Hydroxylations of 2-acetylaminofluorene at positions 5 and 7 were catalyzed at relatively rapid rates, but N- hydroxylation of the same substrate was not catalyzed effectively. Hydroxylation of benzo[a]pyrene occurred preferentially at carbon 3 with much lesser activity at carbon 9 and little or no detectable attack at positions 7 or 1. The results indicated that the 2 beta- and 15 beta-hydroxylation of testosterone and the 10-hydroxylation of warfarin would serve as the most useful probes thus far available for detection of the presence of functional P450IIIA1 isozymes in tissues for which isolation and purification are impractical. The results also indicated a very broad, yet selective substrate specificity for the steroid-inducible P450IIIA1.

Volume 34, Issue 5, pp. 628-637, 11/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
MutagenesisHome page
V. Yoxall, M. Umachandran, J. Wilson, P. Kentish, and C. Ioannides
Black tea intake modulates the excretion of urinary mutagens in rats exposed to 6-aminochrysene: induction of cytochromes P450 by 6-aminochrysene in the rat
Mutagenesis, January 1, 2005; 20(1): 23 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Chen, E. Tan, J. R. Strauss, Z. Zhang, J. E. Fenyk-Melody, C. Booth-Genthe, T. H. Rushmore, R. A. Stearns, D. C. Evans, T. A. Baillie, et al.
Effect of Quinidine on the 10-Hydroxylation of R-Warfarin: Species Differences and Clearance Projection
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. Desaulniers, K. Leingartner, B. Musicki, A. Yagminas, G.-H. Xiao, J. Cole, L. Marro, M. Charbonneau, and B. K. Tsang
Effects of Postnatal Exposure to Mixtures of Non-ortho-PCBs, PCDDs, and PCDFs in Prepubertal Female Rats
Toxicol. Sci., October 1, 2003; 75(2): 468 - 480.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. G. Wade, W. G. Foster, E. V. Younglai, A. McMahon, K. Leingartner, A. Yagminas, D. Blakey, M. Fournier, D. Desaulniers, and C. L. Hughes
Effects of Subchronic Exposure to a Complex Mixture of Persistent Contaminants in Male Rats: Systemic, Immune, and Reproductive Effects
Toxicol. Sci., May 1, 2002; 67(1): 131 - 143.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
G. Amato, V. Longo, A. Mazzaccaro, and P. G. Gervasi
Chlorzoxazone 6-Hydroxylase and p-Nitrophenol Hydroxylase as the Most Suitable Activities for Assaying Cytochrome P450 2E1 in Cynomolgus Monkey Liver
Drug Metab. Dispos., May 1, 1998; 26(5): 483 - 489.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
S. H. Lee and J. T. Slattery
Cytochrome P450 Isozymes Involved in Lisofylline Metabolism to Pentoxifylline in Human Liver Microsomes
Drug Metab. Dispos., December 1, 1997; 25(12): 1354 - 1358.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
R. W. Nims, R. A. Prough, C. R. Jones, D. L. Stockus, K. H. Dragnev, P. E. Thomas, and R. A. Lubet
In Vivo Induction and in Vitro Inhibition of Hepatic Cytochrome P450 Activity by the Benzodiazepine Anticonvulsants Clonazepam and Diazepam
Drug Metab. Dispos., June 1, 1997; 25(6): 750 - 756.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics